Baker and Fraser identified factors that may impact the quality of a life (QOL) for a patient following graft-versus-host disease. These can help to identify a patient who may benefit from closer monitoring and more aggressive management. The authors are from the University of Minnesota and Royal Children's Hospital in Queensland, Australia.

To read more or access our algorithms and calculators, please log in or register.